1. Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial. (May 2021) Authors: Thomsen, M.S.; Berg, M.; Zimmermann, S.; Lutz, C.M.; Makocki, S.; Jensen, I.; Hjelstuen, M.H.B.; Pensold, S.; Hasler, M.P.; Jensen, M.-B.; Offersen, B.V. Journal: Clinical and translational radiation oncology Issue: Volume 28(2021) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1352 Locally advanced NSCLC: performance status based eligibility for adjuvant check point inhibitor. (April 2019) Authors: Persson, G.; Schytte, T.; Appelt, A.L.; Borissova, S.; Brink, C.; Hansen, T.S.; Hoffmann, L.; Josipovic, M.; Khalil, A.A.; Knap, M.M.; Lund, M.D.; Lutz, C.M.; Møller, D.S.; Nielsen, T.B.; Nielsen, M.; Ottosson, W.; Pøhl, M.; Thomsen, J.B.; Hansen, O. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1614: Uncertainty of dose-volume constraints obtained from radiation pneumonitis dose-response analysis. (May 2017) Authors: Lutz, C.M.; Møller, D.S.; Hoffmann, L.; Khalil, A.A.; Knap, M.M.; Alber, M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1932: Quality assurance in implementing a national dose escalation trial in NSCLC – report from NARLAL2. (April 2016) Authors: Nielsen, T.B.; Brink, C.; Moeller, D.S.; Hoffmann, L.; Lutz, C.M.; Appelt, A.L.; Lund, M.D.; Nielsen, M.S.; Ottosson, W.; Khalil, A.A.; Knap, M.M.; Hansen, O.; Schytte, T. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0439 Geometric and dosimetric stability of high FDG-uptake volumes during dose escalated RT of NSCLC. (May 2022) Authors: Møller, D.S.; Hoffmann, L.; Haraldsen, A.; Knap, M.M.; Khalil, A.A.; Lutz, C.M. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC-0450 Model-based selection of NSCLC patients for proton therapy with heterogeneous dose distributions. (May 2022) Authors: van Bogerijen, G.H.; Fuglsang Jensen, M.; Lykkegaard Ehmsen, M.; Hoffmann, L.; Shamshad, M.; Lutz, C.M.; Knap, M.M.; Mortensen, H.R.; Møller, D.S.; Nuyttens, J.J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial. (April 2016) Authors: Moeller, D.S.; Hoffmann, L.; Lutz, C.M.; Nielsen, T.B.; Brink, C.; Appelt, A.L.; Lund, M.D.; Nielsen, M.S.; Ottosson, W.; Khalil, A.A.; Knap, M.M.; Hansen, O.; Schytte, T. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PD-0664 Risk factors of radiation pneumonitis in modern adaptive radiotherapy. (May 2022) Authors: Lutz, C.M.; Møller, D.S.; Appelt, A.; Alber, M.; Hoffmann, L.; Khalil, A.A.; Holt, M.I.; Kandi, M.; Schmidt, H.H.; Tvilum, M.; Knap, M.M. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PD-0846 Tumor match and adaptive radiotherapy reduce risk of radiation pneumonitis and increase survival. (August 2021) Authors: Møller, D.S.; Lutz, C.M.; Alber, M.; Khalil, A.A.; Holt, M.I.; Schmidt, H.H.; Appelt, A.L.; Knap, M.M.; Hoffmann, L. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PD-0876 First-failure prediction model for locally advanced non-small cell lung cancer - External validation. (August 2021) Authors: Lutz, C.M.; Knap, M.M.; Møller, D.S.; Hoffmann, L.; Khalil, A.A.; Håkansson, K.E.; Persson, G.; Bentzen, S.; Nygård, L.; Vogelius, I. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗